Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
November 19, 2001
- Comprehensive Research Necessary in Psychiatry: Seminar
November 12, 2001
- ARB Effective for Heart Failure: Novartis Lecture
November 12, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 12, 2001
- REGULATORY NEWS IN BRIEF
November 12, 2001
- Drug Cost Ratio Down to Record Low of 22.8%
November 12, 2001
- WORLD NEWS IN BRIEF
November 12, 2001
- BULLETIN
November 12, 2001
- DIAGNOSTIC NEWS IN BRIEF
November 12, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
November 12, 2001
- EFPIA Stresses That Reforms Are Needed to Promote Innovation
November 12, 2001
- Sankyo Planning Late PII Study on Pitavastatin in US
November 12, 2001
- BI's Equity Stake in SSP exceeds 50%
November 12, 2001
- NEW PRODUCTS NEWS IN BRIEF
November 12, 2001
- Similar Function Comparison Method for Medical Materials Proposed
November 12, 2001
- AstraZeneca to Increase Share in Japan to 1.7% at End of 2001: CE McKillop
November 12, 2001
- Terumo Licenses New APD System from Debiotech of Spain
November 12, 2001
- BUSINESS NEWS IN BRIEF
November 12, 2001
- GL for Global Drug Development Needed: JPMA Expert
November 12, 2001
- Makers Providing More Products in Small Packages: Yano Report
November 12, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…